Dose-related effects of enzyme-generated oxidants on the biochemistry and morphology of the hamster lung.
Reactive oxygen species (ROS) have been closely associated with a number of pathological disorders, including interstitial pulmonary fibrosis. While models of ROS-induced fibrosis offer advantages over chemically-induced fibrosis, the biochemical and morphological features of ROS-induced fibrosis have yet to be extensively documented. In this study, we evaluated the effect of initial ROS dose on lung injury and repair. Male hamsters received a single dose of glucose, glucose oxidase and lactoperoxidase via the intratracheal route. From 3 to 14 days post-treatment, a significant dose-related body weight loss was observed. There was a trend towards greater mortality with increasing dose. After 2 weeks, we noted significant, dose-related increases in lung levels of collagen, lipid peroxidation products, nucleic acids, and protein. Similarly, total lung catalase, lactic dehydrogenase and glutathione reductase activities were also elevated significantly above control values in a dose-related fashion. A concurrent, dose-dependent thickening of alveolar septa in ROS-treated lungs was composed of epithelial hyperplasia, hyperemia, edema and accumulations of interstitial fibers and macrophages. Interstitial and alveolar macrophages in ROS-induced lesions were enlarged and contained numerous primary and secondary lysosomes. These results demonstrate that, in the hamster lung, injury induced by enzyme-generated ROS can initiate dose-dependent fibroproliferative changes which eventuate into interstitial fibrosis.
Nakashima
J M
JM
Department of Veterinary Pharmacology and Toxicology, School of Veterinary Medicine, University of California, Davis 95616.
Hyde
D M
DM
Giri
S N
SN
D000818:Animals; D002374:Catalase / Q000378:metabolism; D003094:Collagen / Q000378:metabolism; D006224:Cricetinae; D005947:Glucose / Q000494:pharmacology; D005949:Glucose Oxidase / Q000378:metabolism* / Q000494:pharmacology; D005980:Glutathione Reductase / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007784:Lactoperoxidase / Q000378:metabolism* / Q000494:pharmacology; D015227:Lipid Peroxidation; D008264:Macrophages / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D009696:Nucleic Acids / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism / Q000633:toxicity*; D010544:Peroxidases / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology
D009696:Nucleic Acids; D011506:Proteins; D003094:Collagen; D007770:L-Lactate Dehydrogenase; D005949:Glucose Oxidase; D007784:Lactoperoxidase; D010544:Peroxidases; D002374:Catalase; D005980:Glutathione Reductase; D005947:Glucose; D010100:Oxygen